The study objectives are to assess safety and effectiveness, measured acutely and at the 30-day visit after implantation of the Valiant Captivia physician fenestrated Stent Graft.
Clinical utility measures throughout the procedure and until discharge will be assessed
Subject is at least 18 years of age.
Subject understands and has signed an Informed Consent approved by the Sponsor for this study.
Subject must be considered a candidate for revascularisation of BT, LCCA and LSA.
Subject must be able to tolerate surgical revascularisation of BT, LCCA and LSA.
Subject has an aneurysmal, tortuous, or atherosclerotic LSA.
Subject has an aneurysmal, tortuous, or atherosclerotic LCCA.
Subject has an aneurysmal, tortuous, or atherosclerotic BT.
Subject has an ascending aorta diameter > 40 mm
Ceric Sàrl
Lead sponsor
European Cardiovascular Research Center
Collaborator